Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Millennium submits supplemental NDA for Velcade

Oct. 1, 2004

Pharmacyclics identifies potential development candidate from a series of sapphyrin derivatives

Oct. 1, 2004

Novel VEGFR2/PDGFR kinase inhibitor with antitumor and antiangiogenic activity presented by Bayer

Oct. 1, 2004

Inhibition of SOD1 via copper depletion results in inhibition of angiogenesis

Oct. 1, 2004

ABP-309: a second-generation VEGFR tyrosine kinase inhibitor with a promising preclinical profile

Oct. 1, 2004

First clinical results reported for AMG-706 in patients with advanced tumors

Oct. 1, 2004

Selective inhibitors of PKB/Akt designed at Astex

Oct. 1, 2004

Extension of indication recommended for Taxotere in E.U.

Sep. 30, 2004

Preliminary data reported from phase I trial of antiangiogenic peptide

Sep. 30, 2004

CombinatoRx and ABC2 establish brain cancer collaboration

Sep. 30, 2004

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...